Unknown

Dataset Information

0

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).


ABSTRACT:

Purpose

GOG-259 was a 3-arm randomized controlled trial of two web-based symptom management interventions for patients with recurrent ovarian cancer. Primary aims were to compare the efficacy of the nurse-guided (Nurse-WRITE) and self-directed (SD-WRITE) interventions to Enhanced Usual Care (EUC) in improving symptoms (burden and controllability) and quality of life (QOL).

Methods

Patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer with 3+ symptoms were eligible for the study. Participants completed baseline (BL) surveys (symptom burden and controllability and QOL) before random assignment. WRITE interventions lasted 8 weeks to develop symptom management plans for three target symptoms. All women received EUC: monthly online symptom assessment with provider reports; online resources; and every 2-week e-mails. Outcomes were evaluated at 8 and 12 weeks after BL. Repeated-measures modeling with linear contrasts evaluated group by time effects on symptom burden, controllability, and QOL, controlling for key covariates.

Results

Participants (N = 497) reported mean age of 59.3 ± 9.2 years. At BL, 84% were receiving chemotherapy and reported a mean of 14.2 ± 4.9 concurrent symptoms, most commonly fatigue, constipation, and peripheral neuropathy. Symptom burden and QOL improved significantly over time (P < .001) for all three groups. A group by time interaction (P < .001) for symptom controllability was noted whereby both WRITE intervention groups had similar improvements from BL to 8 and 12 weeks, whereas EUC did not improve over time.

Conclusion

Both WRITE Intervention groups showed significantly greater improvements in symptom controllability from BL to 8 and BL to 12 weeks compared with EUC. There were no significant differences between Nurse-WRITE and SD-WRITE. SD-WRITE has potential as a scalable intervention for a future implementation study.

SUBMITTER: Donovan HS 

PROVIDER: S-EPMC9061156 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).

Donovan Heidi S HS   Sereika Susan M SM   Wenzel Lari B LB   Edwards Robert P RP   Knapp Judith E JE   Hughes Susan H SH   Roberge Mary C MC   Thomas Teresa H TH   Klein Sara Jo SJ   Spring Michael B MB   Nolte Susan S   Landrum Lisa M LM   Casey A Catherine AC   Mutch David G DG   DeBernardo Robert L RL   Muller Carolyn Y CY   Sullivan Stephanie A SA   Ward Sandra E SE  

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20220207 13


<h4>Purpose</h4>GOG-259 was a 3-arm randomized controlled trial of two web-based symptom management interventions for patients with recurrent ovarian cancer. Primary aims were to compare the efficacy of the nurse-guided (Nurse-WRITE) and self-directed (SD-WRITE) interventions to Enhanced Usual Care (EUC) in improving symptoms (burden and controllability) and quality of life (QOL).<h4>Methods</h4>Patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer with 3+ sympto  ...[more]

Similar Datasets

| S-EPMC8805698 | biostudies-literature
| S-EPMC6980744 | biostudies-literature
| S-EPMC6235144 | biostudies-literature
| S-EPMC5815909 | biostudies-literature
| S-EPMC6941471 | biostudies-literature
| S-EPMC8084973 | biostudies-literature
| S-EPMC5756518 | biostudies-literature
| S-EPMC10040434 | biostudies-literature
| S-EPMC6546175 | biostudies-literature